Roka Bioscience: BRIEF-Edward Painter dissolves share stake in Roka Bioscience
* Edward Painter, CEO of A2A Pharmaceuticals, dissolves share stake in Roka Bioscience Inc as of Oct 20 - SEC filing Source text: (http://bit.ly/2ladEo7) Further company coverage:
Read full article »
CEO
Roka Bioscience is a molecular diagnostics company that focuses on developing and commercializing pathogen testing solutions for the food industry.
Read more